Entera Bio Ltd. (ENTX)
2.92
-0.10
(-3.31%)
USD |
NASDAQ |
Oct 23, 16:00
2.905
-0.02
(-0.51%)
After-Hours: 20:00
Entera Bio Price : 2.92 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.99 | 3.02 | 2.86 | 2.92 | 256927.0 |
| Oct 22, 2026 | 3.01 | 3.04 | 2.901 | 3.02 | 629476.0 |
| Oct 21, 2026 | 3.12 | 3.20 | 2.96 | 3.05 | 784597.0 |
| Oct 20, 2026 | 2.79 | 3.26 | 2.79 | 3.02 | 791928.0 |
| Oct 19, 2026 | 2.66 | 2.97 | 2.62 | 2.94 | 953139.0 |
| Oct 16, 2026 | 2.72 | 2.75 | 2.62 | 2.68 | 572891.0 |
| Oct 15, 2026 | 2.49 | 2.82 | 2.49 | 2.77 | 1.448M |
| Oct 14, 2026 | 2.47 | 2.565 | 2.46 | 2.50 | 784486.0 |
| Oct 13, 2026 | 2.65 | 2.65 | 2.435 | 2.49 | 755300.0 |
| Oct 12, 2026 | 2.66 | 2.775 | 2.639 | 2.65 | 305689.0 |
| Oct 09, 2026 | 2.51 | 2.72 | 2.505 | 2.66 | 1.584M |
| Oct 08, 2026 | 2.48 | 2.52 | 2.45 | 2.50 | 421033.0 |
| Oct 07, 2026 | 2.52 | 2.58 | 2.45 | 2.51 | 679477.0 |
| Oct 06, 2026 | 2.66 | 2.67 | 2.53 | 2.53 | 621168.0 |
| Oct 05, 2026 | 2.89 | 2.89 | 2.62 | 2.62 | 1.255M |
| Oct 02, 2026 | 2.89 | 2.90 | 2.82 | 2.86 | 100701.0 |
| Oct 01, 2026 | 2.89 | 3.00 | 2.81 | 2.89 | 640880.0 |
| Sep 30, 2026 | 2.67 | 2.975 | 2.57 | 2.91 | 520976.0 |
| Sep 29, 2026 | 2.70 | 2.72 | 2.66 | 2.69 | 160846.0 |
| Sep 28, 2026 | 2.80 | 2.89 | 2.645 | 2.69 | 340911.0 |
| Sep 25, 2026 | 2.91 | 2.91 | 2.70 | 2.745 | 776301.0 |
| Sep 24, 2026 | 2.78 | 2.88 | 2.71 | 2.80 | 234001.0 |
| Sep 23, 2026 | 3.01 | 3.01 | 2.70 | 2.81 | 858158.0 |
| Sep 22, 2026 | 3.02 | 3.03 | 2.945 | 2.98 | 613718.0 |
| Sep 21, 2026 | 2.93 | 2.97 | 2.86 | 2.96 | 294685.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioLineRx Ltd. | 2.04 |
| XTL Biopharmaceuticals Ltd. | 2.02 |
| Kamada Ltd. | 7.77 |
| Can-Fite BioPharma Ltd. | 1.78 |
| Eocene Ltd. | 3.03 |
Price Related Metrics
| PEG Ratio | -0.225 |
| Price to Book Value | 19.81 |
| Earnings Yield | -12.04% |
| Market Cap | 143.93M |
| PEGY Ratio | -0.225 |